SPRY Deadline Alert: SueWallSt Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026
A securities class action alleges ARS Pharmaceuticals paired specific, confident statements about a July 1, 2026 CVS Caremark formulary date with only generalized risk language, leaving SPRY investors exposed to a 23.9% single-day decline. NEW YORK, Aug. 13, 2026 /PRNewswire/ -- SueWallSt...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is down 29.2% since this was published, 70 days ago.
- CVS Health is down 0.5% since this was published, 70 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.